SAN DIEGO, Sept. 12, 2019 — Medical Marijuana, Inc. (OTC:MJNA) (“the Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply...
SAN DIEGO, June 13, 2019 — Medical Marijuana, Inc. (OTC:MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply...
NEW YORK, May 14, 2019 — Medical Marijuana, Inc. (MJNA), the first-ever publicly traded cannabis company in the United States, today announced that the Company’s major investment company AXIM® Biotechnologies, Inc. (AXIM) (“AXIM”), a world...
SAN DIEGO, April 10, 2019 — Medical Marijuana, Inc. (OTC:MJNA), the first-ever publicly traded cannabis company in the United States, announced that its investment company AXIM® Biotechnologies (“AXIM® Biotech” or “AXIM”) (OTCQB:AXIM), a...
SAN DIEGO, March 27, 2019 — Medical Marijuana, Inc. (OTC:MJNA), the first-ever publicly traded cannabis company in the United States, announced that its portfolio company AXIM® Biotechnologies (“AXIM® Biotech” or “AXIM”) (OTCQB:AXIM), a...
Hemp farmers affected by government shutdown, a look at global cannabis legalization, and CBD for skin care among recent Medical Marijuana, Inc. news. The future of hemp cultivation in America, shifting cannabis policy in Mexico, and CBD beauty products are trending...